SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir ($PLTR) is trending amid debates over its valuation and news of Michael Burry's short position, which has sparked both fear and defiance among investors. Community discussions revolve around whether the stock is overhyped, with some bulls arguing that its growth potential justifies the valuation, while bears point to potential downside risks and PE ratios.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending due to news of potential price cuts on weight-loss drugs through a Trump administration deal, sparking mixed reactions from the community; some fear margin erosion while others anticipate increased accessibility and volume growth. The stock's movement is further influenced by an ongoing bidding war with Pfizer for Metsera, reflecting Novo Nordisk's strategic efforts to bolster its pipeline in the competitive obesity market.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

$SNAP is trending due to a reported $400M AI partnership with Perplexity, a $500M share buyback program, and better-than-expected earnings, sparking bullish sentiment. The community is discussing the potential long-term impact of these catalysts and whether the stock can sustain its gains. Some are expressing skepticism, citing the company's history of not holding onto post-earnings rallies, while others point to the AI deal as a game changer.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is trending as the community discusses potential buying opportunities amid recent price declines, with some seeing the current market cap relative to cash holdings as a positive signal. Concerns linger around trust in management and the timing of share buybacks, while others suggest short sellers are manipulating the stock price. Bullish sentiment remains, with some anticipating a rerating after earnings and highlighting the company's contracts and potential for growth.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

CELH is trending despite a large drop after earnings, with community members debating whether the decline is an overreaction or a sign of deeper issues related to distribution and acquisitions. Bullish investors are citing strong revenue growth and a partnership with PepsiCo, while bears express concerns about profitability and market share. Discussions also involve technical analysis, options flow, and potential price movements.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Lilly is trending as community members discuss the potential impact of a White House deal on weight loss drug pricing and Medicare coverage, with some anticipating a surge to $1000. Community members are actively debating the competitive landscape, pipeline potential beyond weight loss, and acquisition possibilities, particularly around GLP-1 drugs. There is a mix of bullish sentiment surrounding strong earnings and skepticism about high valuations.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending as the community debates its valuation and future prospects amidst discussions of an AI bubble. Recent news and commentary, including concerns about China's AI advancements and potential government involvement, have sparked mixed reactions. Investors are closely watching NVIDIA's upcoming earnings report for further insights.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is trending amidst community discussion surrounding its battery technology and potential catalysts, including a possible product unveiling at CES 2026. Recent messages reveal a mix of bullish and bearish sentiment, with some traders focusing on short-term price action and others emphasizing the long-term potential of the company's technology. Community members are actively debating the impact of potential delays and speculating about upcoming catalysts.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingo ($DUOL) is trending as traders discuss its recent price action and potential for a rebound following earnings, despite weaker-than-expected Q4 guidance that initially triggered a selloff. The community is weighing the company's growth prospects against concerns about competition from AI-powered language tools. Bullish investors are emphasizing the company's strong user base and potential for long-term growth, while bears point to valuation concerns and potential disruption from free AI alternatives.

e.l.f. Beauty, Inc. is a holding company, which engages in the provision of inclusive, accessible, clean, vegan and cruelty free cosmetics and skin care products. The company focuses on the e-commerce, national retailers and international business channels. Its brands include elf, elf skin, naturium, well people, and keys soulcare. The company was founded in 2004 and is headquartered in Oakland, CA.

e.l.f. Beauty Inc

e.l.f. Beauty is trending downwards significantly, sparking community discussion around potential bottom levels and whether the dip represents a buying opportunity or a falling knife scenario. The steep decline follows concerning forward guidance and tariff impacts, with some traders closely watching key support levels for potential rebounds. Sentiment is mixed, with some viewing the drop as an overreaction and others anticipating further declines.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PM mOOvers 👀 
 
$EXAS -Exact Sciences Unveils Data on Blood-Based Colorectal Cancer Test at ESMO 
 
$NUVL - Nuvalent jumps 19% on $350M equity offering 
 
$IOBT -IO Biotech share are trading higher after announced promising data from the Phase 2 basket trial of IO102-IO103, the company&#39;s lead investigational therapeutic cancer vaccine candidate, in combination with Merck&#39;s anti-PD-1 therapy KEYTRUDA at the 2024 ESMO Congress. 
 
$MODV -Modivcare Has Revised Its 2024 Adjusted EBITDA Forecast From $185M–$195M To $170M–$180M Due To Pricing Accommodations In NEMT Segment. The Company Also Anticipates 2025 Adjusted EBITDA Growth Of Over 10% 
 
$EVAX -Evaxion Biotech shares are trading higher after the company announced one-year data from the ongoing phase 2 trial with its lead asset EVX-01.

Steve

Rene Olsen

Russell Smith

Steven Baker

StockTwits Web

Exact Sciences Corp.

Evaxion Biotech

ModivCare Inc

IO Biotech Inc

Nuvalent Inc - Ordinary Shares - Class A

 -Exact Sciences Unveils Data on Blood-Based Colorectal Cancer Test at ESMO 
 


 - Nuvalent jumps 19% on $350M equity offering 
 


 -IO Biotech share are trading higher after announced promising data from the Phase 2 basket trial of IO102-IO103, the company's lead investigational therapeutic cancer vaccine candidate, in combination with Merck's anti-PD-1 therapy KEYTRUDA at the 2024 ESMO Congress. 
 


 -Modivcare Has Revised Its 2024 Adjusted EBITDA Forecast From $185M–$195M To $170M–$180M Due To Pricing Accommodations In NEMT Segment. The Company Also Anticipates 2025 Adjusted EBITDA Growth Of Over 10% 
 


 -Evaxion Biotech shares are trading higher after the company announced one-year data from the ongoing phase 2 trial with its lead asset EVX-01.